Changes in 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D are associated with maturation of regulatory T lymphocytes in patients with chronic pancreatitis: a randomized controlled trial

TY - JOUR

T1 - Changes in 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D are associated with maturation of regulatory T lymphocytes in patients with chronic pancreatitis

T2 - a randomized controlled trial

AU - Bang, Ulrich Christian

AU - Brandt, Lea

AU - Benfield, Thomas

AU - Jensen, Jens-Erik Beck

PY - 2012/11

Y1 - 2012/11

N2 - OBJECTIVES: We studied the impact of changes in 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2D) on regulatory T lymphocytes (Tregs) in patients with chronic pancreatitis (CP) and fat malabsorption in a prospective clinical trial. METHODS: The patients were randomized to 1 of 3 treatments during 10 weeks: weekly UV-B in a tanning bed (group A), 1520-IU/d vitamin D supplement (group B), or placebo (group C). A placebo tanning bed was used in groups B and C. We determined the levels of CD4 Tregs (CD3CD4CD25CD127lowFoxP3) and CD8 Tregs (CD3CD8CD25CD127lowFoxP3), together with 25OHD and 1,25(OH)2D. For baseline comparisons, we included 8 healthy individuals. Of the 30 included patients, 27 (group A, 7 patients; group B, 9 patients; and group C, 11 patients) completed the protocol. RESULTS: The baseline levels of CD4 Tregs relative to total CD4 count were higher in 22 patients with CP compared with healthy controls (2.8% vs 1.9%, P < 0.05) and were comparable for CD8+ Tregs (0.13% vs 0.05%, P = 0.3). Increases in levels of CD4 Tregs correlated to changes in 1,25(OH)2D (2% per 100 pmol/L, P = 0.002) and 25OHD (3% per 100 nmol/L, P = 0.01). CONCLUSIONS: Patients with CP have elevated relative levels of CD4 Tregs. Increases in 25OHD and 1,25(OH)2D were both related with increases in levels of Tregs.

AB - OBJECTIVES: We studied the impact of changes in 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2D) on regulatory T lymphocytes (Tregs) in patients with chronic pancreatitis (CP) and fat malabsorption in a prospective clinical trial. METHODS: The patients were randomized to 1 of 3 treatments during 10 weeks: weekly UV-B in a tanning bed (group A), 1520-IU/d vitamin D supplement (group B), or placebo (group C). A placebo tanning bed was used in groups B and C. We determined the levels of CD4 Tregs (CD3CD4CD25CD127lowFoxP3) and CD8 Tregs (CD3CD8CD25CD127lowFoxP3), together with 25OHD and 1,25(OH)2D. For baseline comparisons, we included 8 healthy individuals. Of the 30 included patients, 27 (group A, 7 patients; group B, 9 patients; and group C, 11 patients) completed the protocol. RESULTS: The baseline levels of CD4 Tregs relative to total CD4 count were higher in 22 patients with CP compared with healthy controls (2.8% vs 1.9%, P < 0.05) and were comparable for CD8+ Tregs (0.13% vs 0.05%, P = 0.3). Increases in levels of CD4 Tregs correlated to changes in 1,25(OH)2D (2% per 100 pmol/L, P = 0.002) and 25OHD (3% per 100 nmol/L, P = 0.01). CONCLUSIONS: Patients with CP have elevated relative levels of CD4 Tregs. Increases in 25OHD and 1,25(OH)2D were both related with increases in levels of Tregs.

KW - Aged

KW - Dietary Supplements

KW - Female

KW - Humans

KW - Lipid Metabolism

KW - Lymphocyte Activation/drug effects

KW - Malabsorption Syndromes/blood

KW - Male

KW - Middle Aged

KW - Pancreatitis, Chronic/blood

KW - T-Lymphocytes, Regulatory/drug effects

KW - Ultraviolet Therapy

KW - Vitamin D/administration & dosage

U2 - 10.1097/MPA.0b013e31824da377

DO - 10.1097/MPA.0b013e31824da377

M3 - Journal article

C2 - 22695134

SN - 0885-3177

VL - 41

SP - 1213

EP - 1218

JO - Pancreas

JF - Pancreas

IS - 8

ER -